Scarica l'app Stockscreener
73.17
2.49%
1.78
Dopo l'orario di chiusura:
73.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$71.39
Aprire:
$71.25
Volume 24 ore:
1.69M
Relative Volume:
1.89
Capitalizzazione di mercato:
$11.63B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
48.14
EPS:
1.52
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-3.33%
1M Prestazione:
+6.48%
6M Prestazione:
-1.82%
1 anno Prestazione:
-3.55%
Intervallo 1D:
$71.25
$74.27
Intervallo di 1 settimana:
$69.48
$77.62
Portata 52W:
$61.16
$85.57
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
73.17 | 11.63B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Yahoo Finance
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Bio-Techne partners with Waters for biotherapeutic tech - Investing.com
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - Yahoo Finance
ScaleReady awards a G-Rex® Grant to Moonlight Bio - Yahoo Finance
Lord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in November - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion Bank - MarketBeat
Oddo BHF Asset Management Sas Invests $1.19 Million in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Barclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? - MSN
National Bank of Canada FI Purchases 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - Quantisnow
S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's
West Sac-based GeminiBio acquires a large serum producer's brands, customers - The Business Journals
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - Yahoo Finance
Wellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
State Street Corp Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Tenere Capital LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Worldquant Millennium Advisors LLC Buys 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Polar Asset Management Partners Inc. Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Janus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum? - Yahoo Finance
PEAK6 Investments LLC Invests $698,000 in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Bio-Techne Co. (NASDAQ:TECH) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Why Bio-Techne Corp (TECH) Is Set to Outperform the Market: Insi - GuruFocus.com
Bamco Inc. NY Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Should You Continue to Retain Bio-Techne Stock in Your Portfolio? - Yahoo Finance
BNP Paribas Financial Markets Sells 52,235 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
The Manufacturers Life Insurance Company Has $15.93 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
American Capital Management Inc. Has $89.07 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Fred Alger Management LLC Has $52.07 Million Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $81.78 - MarketBeat
TECH (Bio-Techne) 3-Year Revenue Growth Rate : 7.80% (As of Sep. 2024) - GuruFocus.com
Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Dai ichi Life Insurance Company Ltd Has $423,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE - Quantisnow
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE – Company Announcement - Financial Times
Charles Schwab Investment Management Inc. Has $113.02 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Position Raised by Cerity Partners LLC - MarketBeat
Bio-Techne (TECH) Shares Cross Above 200 DMA - Nasdaq
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Eagle Asset Management Inc. - MarketBeat
Massachusetts Financial Services Co. MA Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Mutual of America Capital Management LLC Purchases 8,852 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne (MEX:TECH) Dividend Payout Ratio : 0.19 (As of Sep. 2024) - GuruFocus.com
Bio-Techne (MEX:TECH) Debt-to-Equity : 0.19 (As of Sep. 2024) - GuruFocus.com
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? - Inkl
Bio-Techne (BSP:T1CH34) Enterprise Value : R$70,339 Mil (As of Nov. 21, 2024) - GuruFocus.com
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hippel James | CFO |
Nov 01 '24 |
Option Exercise |
0.00 |
13,159 |
0 |
113,085 |
| HIGGINS JOHN L | Director |
Sep 12 '24 |
Option Exercise |
22.95 |
6,000 |
137,700 |
48,608 |
| Kelderman Kim | Chief Executive Officer |
Aug 29 '24 |
Option Exercise |
66.97 |
1,492 |
99,919 |
41,434 |
| Bohnen Shane | SVP - General Counsel |
Aug 15 '24 |
Option Exercise |
0.00 |
49 |
0 |
1,696 |
| BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Option Exercise |
22.95 |
16,000 |
367,200 |
59,401 |
| BAUMGARTNER ROBERT V | Director |
Aug 08 '24 |
Sale |
72.10 |
16,000 |
1,153,664 |
43,401 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):